<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144434">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01220414</url>
  </required_header>
  <id_info>
    <org_study_id>H-2010-0087</org_study_id>
    <nct_id>NCT01220414</nct_id>
  </id_info>
  <brief_title>Attenuation of Pain in Men and Women</brief_title>
  <official_title>Attenuation of Pain in Men and Women: Mechanisms of Exercise-Induced Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine opioid and endocannabinoid mechanisms of
      exercise-induced analgesia in men and women.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain threshold, pain ratings, and temporal summation</measure>
    <time_frame>Before and immediately following the two experimental sessions</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Men</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Women</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naltrexone,</intervention_name>
    <description>50 mg of naltrexone</description>
    <arm_group_label>Men</arm_group_label>
    <arm_group_label>Women</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>sugar pill</description>
    <arm_group_label>Men</arm_group_label>
    <arm_group_label>Women</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Healthy men and women

        Exclusion Criteria:

          -  current cardiac or other chronic diseases (e.g., cancer, diabetes, hypertension,
             kidney disease); routine use of prescriptive medications; history of vasovagal
             response to phlebotomy; an allergy to naltrexone; pregnancy; current smokers; current
             use of recreational drugs; history of substance abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kelli F Koltyn, PhD</last_name>
    <phone>608-262-4234</phone>
    <email>Koltyn@education.wisc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Wisconsin-Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>52706</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelli F Koltyn, Ph.D.</last_name>
      <phone>608-262-4234</phone>
      <email>Koltyn@education.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Kelli F Koltyn, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <lastchanged_date>October 15, 2010</lastchanged_date>
  <firstreceived_date>September 28, 2010</firstreceived_date>
  <responsible_party>
    <name_title>Kelli F. Koltyn</name_title>
    <organization>University of Wisconsin</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Naltrexone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
